Results 181 to 190 of about 76,426 (249)

When lymph defies benign surgery: postoperative chylous fistula. [PDF]

J Surg Case Rep
León GA, Lemarie AS, Cisneros WJ, Velasco SA, Montenegro ED, Campoverde TP.   +5 more
europepmc   +1 more source

The SCARLET Trial: Radiotheranostics in Multiple Myeloma. [PDF]

Radiol Imaging Cancer
Jain S, Graham MM.
europepmc   +1 more source

Thymic Neuroendocrine Tumors: Evolving Insights and Innovative Approaches. [PDF]

JTO Clin Res Rep
Pietroluongo E, Bestvina CM, Brattin R, De Placido P, Di Lello A, Haque W, Esposito A, Bianco R, Choudhury N, Garassino MC.   +9 more
europepmc   +1 more source

Cabergoline monotherapy in GH- and PRL-cosecreting pituitary adenomas. [PDF]

Endocr Oncol
McNeil JM, Candy NC, Jukes AK, De Sousa SMC.   +3 more
europepmc   +1 more source

PCN28 PHARMACOECONOMIC EVALUATION OF THE USE OF SOMATOSTATIN ANALOGS HANDLING THE ASSOCIATED SYMPTOMS OF CARCINOID SYNDROME

, 2009
Guillermo Salinas‐Escudero, Juan‐Pablo Idrovo, L Zapata   +2 more
openalex   +1 more source

Machine Learning Uncovers Novel Predictors of Peptide Receptor Radionuclide Therapy Eligibility in Neuroendocrine Neoplasms. [PDF]

Cancers (Basel)
Sipka G, Farkas I, Bakos A, Maráz A, Mikó ZS, Czékus T, Bukva M, Urbán S, Pávics L, Besenyi Z.   +9 more
europepmc   +1 more source

Efficacy and Safety of Non-Surgical Treatments for Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis. [PDF]

Pharmaceuticals (Basel)
AlQahtani MS, Miutescu B, Domilescu I, Negru S, Popovici D, Gadour E.   +5 more
europepmc   +1 more source

Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: An Uncommon Clinical Challenge. [PDF]

Cureus
Faria R, Balanco L, Almeida V, Ferreira PG.   +3 more
europepmc   +1 more source

Somatostatin receptors in the immune system and immune-mediated disease

, 1999
Annemieke ten Bokum
openalex   +1 more source

Intra-arterial peptide receptor radionuclide therapy (IA-PRRT) in patients with SSTR-expressing neuroendocrine neoplasms: short- and long-term safety and efficacy for up to 13 years. [PDF]

Theranostics
Zhang J, Mensel B, Baum RP.
europepmc   +1 more source